智慧健康科技有限公司 執行董事 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 AI Health Technology Limited 智慧健康科技有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1715） (前稱 Volcano Spring International Holdings Limited 火山邑動國際控股有限公司) 董事會會議通知 智 慧 健 康 科 技 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，董 事 會 會 議 將 於 二 零 二 五 年 八 月 二 十 七 日（星 期 三）舉 行，以 批 准（其 中 包 括）刊 發 本 公 司 及 其 附 屬 公 司 截 至 二 零 二 五 年 六 月 三 十 日 止 六 個 月 的 未 經 審 核 中 期 業 績，以 及 考 慮 派 付 中 期 股 息（如 有）。 承董事會命 趙 傑 香 港，二 零 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 AI Health Technology Limited 智慧健康科技有限公司 （於開曼群島註冊成立的有限公司） (前稱 Volcano Spring International Holdings Limited 火山邑動國際控股有限公司) （股份代號：1715） 盈 利 警 告－虧 損 減 少 本 公 告 乃 由 智 慧 健 康 科 技 有 限 公 司（「本公司」及 其 附 屬 公 司，統 稱「本集團」）根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」）第13.09條及香港法例第 571章證券及期貨條例第XIVA部 項 下 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 作 出。 本 公 司 董 事（「董 事」）會（「董事會」）謹 此 知 會 本 公 司 股 東（「股 東」）及 潛 在 投 資 者， ...

智通财经APP讯，火山邑动国际控股(01715)公布，公司股份于联交所买卖的英文股票简称将 由"VOLCANO SPRING"更改为"AI HEALTH TECH"及中文股票简称将由"火山邑动国际控股"更改为"智 慧健康科技"，自 2025年 8月 13日上午九时正起生效。公司于联交所的股份代号维持不变，为 「1715」。 （原标题：火山邑动国际控股(01715)股票简称将更改为"智慧健康科技"） ...

格隆汇8月8日丨火山邑动国际控股(01715.HK)公告，董事会欣然宣布，根据开曼群岛公司注册处处长发 出更改名称注册证书，建议将公司英文名称由"Volcano Spring International Holdings Limited"更改为"AI Health Technology Limited"，并将中文名称更改为"智慧健康科技有限公司"以取代其现有中文名称"火山 邑动国际控股有限公司"一事已于2025年7月4日起生效。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 AI Health Technology Limited 智慧健康科技有限公司 （於開曼群島註冊成立的有限公司） (前稱 Volcano Spring International Holdings Limited 火山邑動國際控股有限公司) 本 公 司 股 份 於 聯 交 所 買 賣 之 英 文 股 票 簡 稱 將 由「VOLCANO SPRING」更 改 為「AI HEALTH TECH」及 中 文 股 票 簡 稱 將 由「火 山 邑 動 國 際 控 股」更 改 為「智 慧 健 康 科 技」，自 二 零 二 五 年 八 月 十 三 日 上 午 九 時 正 起 生 效。本 公 司 於 聯 交 所 之 股 份 代 號 維 持 不 變，為「1715」。 （股份代號：1715） 更 改 公 司 名 稱、股 票 簡 稱 及公司網站 茲 提 述 智 慧 健 ...

Core Viewpoint - Volcano International Holdings (01715) announced a proposal for a capital restructuring involving a share capital reduction and a share split to address accumulated losses and improve financial position [1] Group 1: Capital Restructuring Details - The proposed capital restructuring includes a share capital reduction by cancelling HKD 0.249 of the paid-up capital for each issued share, reducing the nominal value from HKD 0.25 to HKD 0.001 [1] - Following the capital reduction, the company plans to split the remaining unissued shares with a nominal value of HKD 0.25 into 250 new shares, each with a nominal value of HKD 0.001 [1] - The proceeds from the capital reduction will be used to offset the accumulated losses as of the effective date of the capital reduction, thereby reducing the company's cumulative losses [1]

Volcano Spring International Holdings Limited 火山邑動國際控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1715） 建議股本重組 董 事 會 建 議 向 股 東 提 呈 建 議 進 行 股 本 重 組，當 中 涉 及： 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 一般事項 本 公 司 將 召 開 及 舉 行 股 東 特 別 大 會 以 供 股 東 考 慮 及 酌 情 批 准 股 本 重 組。一 份 載 有（其 中 包 括）股 本 重 組 詳 情、連 同 召 開 股 東 特 別 大 會 之 通 告 及 相 關 代 表 委 任 表 格 之 通 函，預 期 將 於 二 零 二 五 年 八 月 十 五 日（星 期 五）或 之 前 寄 發 予 股 東。 – 1 – (i) 股 本 削 減，據 此 透 過 註 銷 每 股 已 發 行 股 份 之 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 火山邑動國際控股有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01715 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 600,000,000 | HKD | | 0.25 HKD | | 150,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 600,000,000 | HKD | | 0.25 HKD | | 150,000,000 | 本 ...

Group 1 - The core viewpoint of the news highlights the significant stock performance of Volcano International Holdings, with a notable increase in share price and strong year-to-date growth compared to the Hang Seng Index [1] - As of July 23, the Hang Seng Index rose by 1.62% to 25,538.07 points, while Volcano International Holdings' stock price increased by 12.5% to HKD 0.36 per share, with a trading volume of 3.66 million shares and a turnover of HKD 1.24 million [1] - Over the past month, Volcano International Holdings has seen a cumulative increase of 6.67%, and a year-to-date increase of 71.37%, outperforming the Hang Seng Index by 25.27% [1] Group 2 - Financial data shows that as of December 31, 2024, Volcano International Holdings achieved total revenue of HKD 91.885 million, representing a year-on-year growth of 8.91% [1] - The company reported a net profit attributable to shareholders of -HKD 35.85 million, with a year-on-year increase of 27.31%, and a gross margin of 7.06% [1] - The company's debt-to-asset ratio stands at 69.16%, indicating a relatively high level of leverage [1] Group 3 - Currently, there are no institutional investment ratings for Volcano International Holdings [2] - In terms of industry valuation, the average price-to-earnings (P/E) ratio for the household appliances and goods sector is 13.18 times, with a median of 1.62 times [2] - Volcano International Holdings has a P/E ratio of -2.98 times, ranking 70th in the industry, while other companies in the sector have P/E ratios ranging from 1.61 to 3.87 times [2] Group 4 - Volcano International Holdings is a modern large-scale enterprise platform focused on the health industry, primarily engaged in the research, production, sales, and service of health products [2] - The company is listed on the Hong Kong Stock Exchange under the stock code 1715.HK and implements a scientific health strategy, relying on modern technology to establish a comprehensive health product system [2] - Volcano International collaborates with research institutions to continuously conduct health research, aiming to create scientifically-backed health products [2]

Financial Performance - Revenue for the year ended December 31, 2024, increased by 8.9% to RMB 91.9 million from RMB 84.4 million in 2023[12] - Net loss for the year was RMB 36.0 million, an improvement from a net loss of RMB 49.3 million in 2023[13] - Total assets decreased to RMB 137.5 million in 2024 from RMB 165.7 million in 2023, representing a decline of 17%[10] - The company recorded a gross profit of RMB 6.5 million, down from RMB 21.2 million in 2023, indicating a significant decrease in gross margin[9] - Basic and diluted loss per share improved to RMB 0.37 in 2024 from RMB 0.73 in 2023[13] - Total liabilities decreased to RMB 95.1 million in 2024 from RMB 107.5 million in 2023, a reduction of approximately 11.5%[10] - The gross profit margin decreased to 7.1% from 25.1% for the year ended December 31, 2023, primarily due to changes in the product mix and inventory impairment losses[29] Revenue Sources - Revenue from health-related products accounted for 49.1% of total revenue, significantly up from 23.4% in the previous year[21] - Direct sales from consignment stores decreased by 20.9% to RMB 14.4 million, attributed to reduced consumer spending amid economic challenges[24] - Sales revenue from television platforms dropped by 76.2% to RMB 3.5 million, reflecting decreased consumer expenditure through this channel[26] - Revenue from online platforms fell by 64.9% to RMB 7.9 million, mainly due to poor economic conditions affecting consumer spending[27] - Revenue from physical sales locations surged by 148.7% to RMB 65.4 million, driven by the launch of health-related products[28] Cost Management - The company reported a decrease in sales costs to RMB 85.4 million in 2024 from RMB 63.2 million in 2023, reflecting a strategic focus on cost management[9] - Administrative expenses decreased by 22.9% to RMB 14.5 million, primarily due to cost control measures[34] - Research and development expenses decreased by 14.5% to RMB 5.9 million from RMB 6.9 million for the year ended December 31, 2023, primarily due to cost control measures[35] - Financial costs decreased by 45.5% to RMB 4.2 million from RMB 7.7 million for the year ended December 31, 2023, mainly due to the repayment of a loan in July 2024[37] Corporate Governance - The company is committed to establishing good corporate governance practices to enhance transparency and accountability[81] - The board focuses on internal controls and fair disclosure to ensure compliance with legal and business standards[81] - The company aims to create more value for shareholders through effective corporate governance[81] - The company appointed Mr. Zhao Jie as the Executive Director and Chairman on August 1, 2024, ensuring compliance with the corporate governance code regarding the separation of roles[83] - The board has established three committees to assist in fulfilling its responsibilities and promoting effective management[97] ESG and Sustainability - The environmental, social, and governance (ESG) report covers the group's performance from January 1, 2024, to December 31, 2024[153] - The report adheres to the guidelines set by the Hong Kong Stock Exchange for ESG reporting, ensuring the relevance and importance of key performance indicators[154] - Key environmental issues identified include greenhouse gas emissions, energy consumption, and waste management, which are prioritized for monitoring and resolution[163] - The company generated a total of 107 tons of greenhouse gas emissions during the reporting period, a decrease from 168.18 tons in 2023, resulting in an emissions density of 1.55 tons of CO2 per employee compared to 0.82 tons in 2023[174] - The company has set a target to reduce greenhouse gas emissions by 5% by 2027, based on the 2022 baseline[177] Employee and Labor Relations - The total number of full-time employees decreased to 69 as of December 31, 2024, down from 205 as of December 31, 2023[195] - Employee turnover rates for males increased to 35.3% in 2024 from 33.8% in 2023, while female turnover rates rose to 11.5% from 6.0%[196] - The company complies with Chinese labor laws and has not faced any significant disputes or operational disruptions due to labor issues during the reporting period[200] - The company provides social insurance for employees, including retirement, medical, and unemployment benefits, in accordance with applicable Chinese laws[200] Strategic Initiatives - The company plans to establish a joint venture with Shanghai Yougu Health Technology Co., Ltd. to expand into the health industry, focusing on biomedicine and AI technology[15] - The company is exploring potential opportunities to diversify its business segments and create value for shareholders[15] - The group completed a placement of 42,310,000 shares at a price of HKD 0.52 per share, raising approximately HKD 21.0 million, with HKD 20.0 million allocated for repaying other borrowings[63]